Partner Article
Paracetamol may reduce cancer risk
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, according to scientists. A research team from Athens University studied 746,000 women over a six-year period, and found that the risk of cancer fell by 30% when the women took paracetamol regularly. However, the scientists stressed that more research was needed, and women should not take the medicine as a way to guard against the disease due to the risks of long-term paracetamol use - including liver and chronic kidney failure. “Ovarian cancer remains the most fatal gynecological malignancy” says Dr Bonovas of Athen University. “Its high mortality rate – mainly due to a combination of ineffective screening and the limited success of therapies for advanced disease - makes ovarian cancer a major health concern. “Strategies that focus on prevention may therefore provide the most rational approach for reducing deaths from this form of cancer. “Because paracetamol is so widely used, a link with a decreased risk of ovarian cancer could have important public health implications.”
This was posted in Bdaily's Members' News section by Ruth Mitchell .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
OpenAI decision a wake-up call for our tech plans
Understanding the new Employment Rights Act
Why global conflict is a cyber risk for UK SMEs
Improving safety and standards in construction
From economic engine to community ecosystem
Improving North East transport will improve lives
Unlocking investment potential before year end
Give us certainty to deliver better homes
Hormuz: Safe passage - not insurance - the issue
Don't get caught out by employment law change
When literacy thrives, our businesses thrive too
Building a more diverse construction sector